The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine
Open accessAbstract
Molecular pathology diagnostics to subclassify diseases based on pathogenesis are increasingly common in clinical translational medicine. Molecular pathological epidemiology (MPE) is an integrative transdisciplinary science based on the unique disease principle and the disease continuum theory. While it has been most commonly applied to research on breast, lung, and colorectal cancers, MPE can investigate etiologic heterogeneity in non-neoplastic diseases, such as cardiovascular diseases, obesity, diabetes mellitus, drug toxicity, and immunity-related and infectious diseases. This science can enhance causal inference by linking putative etiologic factors to specific molecular biomarkers as outcomes. Technological advances increasingly enable analyses of various -omics, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, metagenomics, microbiome, immunomics, interactomics, etc. Challenges in MPE include sample size limitations (depending on availability of biospecimens or biomedical/radiological imaging), need for rigorous validation of molecular assays and study findings, and paucities of interdisciplinary experts, education programs, international forums, and standardized guidelines. To address these challenges, there are ongoing efforts such as multidisciplinary consortium pooling projects, the International Molecular Pathological Epidemiology Meeting Series, and the Strengthening the Reporting of Observational Studies in Epidemiology-MPE guideline project. Efforts should be made to build biorepository and biobank networks, and worldwide population-based MPE databases. These activities match with the purposes of the Big Data to Knowledge (BD2K), Genetic Associations and Mechanisms in Oncology (GAME-ON), and Precision Medicine Initiatives of the United States National Institute of Health. Given advances in biotechnology, bioinformatics, and computational/systems biology, there are wide open opportunities in MPE to contribute to public health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term colorectal-cancer incidence and mortality after lower endoscopy
Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z. R., Inamura, K., Kim, S. A., Kuchiba, A., Yamauchi, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301969 · Cited by 1,483
Self-citationDogan, S., Shen, R., Ang, D. C., Johnson, M. L., D'Angelo, S. P., Paik, P. K., Brzostowski, E. B., Riely, G. J., Kris, M. G., Zakowski, M. F., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3265 · Cited by 639
Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
Colussi, D., Brandi, G., Bazzoli, F., & Ricciardiello, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816365 · Cited by 429
Lochhead, P., Chan, A. T., Nishihara, R., Fuchs, C. S., Beck, A. H., Giovannucci, E., & Ogino, S. (2015) · Modern Pathology · doi:10.1038/modpathol.2014.81 · Cited by 206
Self-citationZhu, Y., Yang, S. R., Wang, P. P., Savas, S., Wish, T., Zhao, J., Green, R., Woods, M., Sun, Z., Roebothan, B., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.6 · Cited by 49
Research works printed but not linked: 93
- Ogino, 2012, Expert Rev Mol Diagn, 12, 621, 10.1586/erm.12.46 · DOI · Paper page
- Ogino, 2010, J Natl Cancer Inst, 102, 365, 10.1093/jnci/djq031 · DOI · Paper page
- Ogino, 2011, Gut, 60, 397, 10.1136/gut.2010.217182 · DOI · Paper page
- Ogino, 2011, Nat Rev Clin Oncol, 8, 711, 10.1038/nrclinonc.2011.122 · DOI · Paper page
- Kuller, 2013, Am J Epidemiol, 178, 1350, 10.1093/aje/kwt239 · doi:10.1093/aje/kwt239
- Ogino, 2013, Cancer Prev Res (Phila, 6, CN06
- Epplein, 2014, Cancer Epidemiol Biomarkers Prev, 23, 2613, 10.1158/1055-9965.EPI-14-0848 · DOI
- Curtin, 2011, Patholog Res Int, 2011, 902674
- Hughes, 2011, PLoS One, 6, e18571, 10.1371/journal.pone.0018571 · DOI
- Jacobs, 2012, Curr Opin Pharmacol, 12, 690, 10.1016/j.coph.2012.07.010 · DOI
- Hughes, 2012, Biochim Biophys Acta, 1825, 77
- Iwagami, 2012, Ann Surg Oncol, 19, 2726, 10.1245/s10434-011-2176-3 · DOI
- Limburg, 2012, Cancer Epidemiol Biomarkers Prev, 21, 681, 10.1158/1055-9965.EPI-11-1168 · doi:10.1158/1055-9965.epi-11-1168
- Hughes, 2012, Int J Epidemiol, 41, 1060, 10.1093/ije/dys055 · DOI
- Ku, 2012, Mod Pathol, 25, 1055, 10.1038/modpathol.2012.62 · DOI
- Rex, 2012, Am J Gastroenterol, 107, 1315, 10.1038/ajg.2012.161 · DOI · Paper page
- Koshiol, 2012, Ann Epidemiol, 22, 520, 10.1016/j.annepidem.2012.03.001 · DOI
- Gay, 2012, J Pathol, 228, 405, 10.1002/path.4085 · DOI
- Galon, 2012, J Transl Med, 10, 205, 10.1186/1479-5876-10-205 · DOI · Paper page
- Chia, 2012, Nat Rev Clin Oncol, 9, 561, 10.1038/nrclinonc.2012.137 · DOI
- Spitz, 2012, Cancer Discov, 2, 1087, 10.1158/2159-8290.CD-12-0424 · DOI
- Shanmuganathan, 2013, J Mol Diagn, 15, 17, 10.1016/j.jmoldx.2012.06.007 · DOI
- Rosty, 2013, Mod Pathol, 26, 825, 10.1038/modpathol.2012.240 · DOI · Paper page
- Weijenberg, 2013, Curr Nutr Rep, 2, 19, 10.1007/s13668-012-0038-7 · DOI
- Buchanan, 2013, Cancer Epidemiol Biomarkers Prev, 22, 917, 10.1158/1055-9965.EPI-12-1211 · doi:10.1158/1055-9965.epi-12-1211
- Burnett-Hartman, 2013, Cancer Res, 73, 2863, 10.1158/0008-5472.CAN-12-3462 · DOI
- Alvarez, 2013, World J Gastroenterol, 19, 3043, 10.3748/wjg.v19.i20.3043 · DOI
- Hagland, 2013, Dig Surg, 30, 12, 10.1159/000347166 · DOI
- Zaidi, 2013, Prog Lipid Res, 52, 585, 10.1016/j.plipres.2013.08.005 · DOI · Paper page
- Abbenhardt, 2013, Int J Mol Epidemiol Genet, 4, 140
- Hughes, 2013, Cancer Res, 73, 5858, 10.1158/0008-5472.CAN-12-4306 · DOI · Paper page
- Bae, 2013, Br J Cancer, 109, 1004, 10.1038/bjc.2013.430 · DOI
- Amirian, 2013, Infect Agent Cancer, 8, 42, 10.1186/1750-9378-8-42 · DOI
- Hoffmeister, 2013, Cancer Epidemiol Biomarkers Prev, 22, 2303, 10.1158/1055-9965.EPI-13-0239 · DOI
- Araújo, 2013, Pathol Res Pract, 209, 753, 10.1016/j.prp.2013.08.007 · DOI
- Esterhuyse, 2013, Expert Rev Mol Diagn, 13, 625, 10.1586/14737159.2013.811897 · DOI
- Hagland, 2015, Cancer Lett, 356, 273, 10.1016/j.canlet.2014.02.026 · DOI
- Shaheen, 2014, Am J Gastroenterol, 109, 345, 10.1038/ajg.2014.35 · DOI
- Brändstedt, 2014, BMC Cancer, 14, 371, 10.1186/1471-2407-14-371 · DOI
- Coppedè, 2014, Expert Rev Gastroenterol Hepatol, 8, 935, 10.1586/17474124.2014.924397 · DOI
- Bishehsari, 2014, World J Gastroenterol, 20, 6055, 10.3748/wjg.v20.i20.6055 · DOI · Paper page
- Cross, 2014, Cancer, 120, 3049, 10.1002/cncr.28799 · DOI
- Simons, 2014, Cancer Epidemiol Biomarkers Prev, 23, 1852, 10.1158/1055-9965.EPI-13-1285 · DOI
- Haque, 2014, Dig Dis Sci, 59, 2874, 10.1007/s10620-014-3277-1 · DOI
- Ryan, 2014, Cancer Epidemiol, 38, 583, 10.1016/j.canep.2014.07.003 · DOI
- Huser, 2014, Pharmgenomics Pers Med, 7, 275
- Wennersten, 2014, Diagn Pathol, 9, 189, 10.1186/s13000-014-0189-5 · DOI
- Mikeska, 2014, Genes (Basel, 5, 821, 10.3390/genes5030821 · DOI · Paper page
- Campbell, 2014, Cancer Epidemiol Biomarkers Prev, 23, 2694, 10.1158/1055-9965.EPI-14-0541 · doi:10.1158/1055-9965.epi-14-0541
- Witvliet, 2014, Austin J Public Health Epidemiol, 1, id1012
- Li, 2015, Gut, 64, 1419, 10.1136/gutjnl-2014-308260 · DOI
- Wild, 2015, J Natl Cancer Inst, 107, 353, 10.1093/jnci/dju353 · DOI
- Caiazza, 2015, Front Oncol, 5, 19, 10.3389/fonc.2015.00019 · DOI · Paper page
- Ng, 2015, Int J Mol Sci, 16, 2472, 10.3390/ijms16022472 · DOI · Paper page
- Tillmans, 2015, Cancer Epidemiol Biomarkers Prev, 24, 713, 10.1158/1055-9965.EPI-14-0756 · doi:10.1158/1055-9965.epi-14-0756
- Cisyk, 2015, Neoplasia, 17, 306, 10.1016/j.neo.2015.02.001 · DOI
- Weisenberger, 2015, Cancer Epidemiol Biomarkers Prev, 24, 512, 10.1158/1055-9965.EPI-14-1161 · DOI
- Gao, 2015, Austin J Gastroenterol, 2, 1040
- Szylberg, 2015, Gastroenterol Res Pract, 2015, 573814, 10.1155/2015/573814 · DOI
- Wong, 2015, Expert Rev Anticancer Ther, 15, 639, 10.1586/14737140.2015.1038248 · DOI
- Begg, 2015, Cancer Med, 4, 1432, 10.1002/cam4.456 · DOI
- Campbell, 2015, Cancer Epidemiol Biomarkers Prev, 24, 1229, 10.1158/1055-9965.EPI-15-0094 · DOI
- Mehta, 2015, Anal Cell Pathol (Amst, 2015, 367837
- Nishi, 2015, Am J Prev Med, 48, 116, 10.1016/j.amepre.2014.09.031 · DOI
- Ogino, 2015, Cancer Causes Control, 26, 959, 10.1007/s10552-015-0596-2 · DOI
- Ogino, 2012, Am J Epidemiol, 176, 659, 10.1093/aje/kws226 · DOI
- Ogino, 2013, Mod Pathol, 26, 465, 10.1038/modpathol.2012.214 · DOI · Paper page
- Suzuki, 2014, Biochem Biophys Res Commun, 455, 35, 10.1016/j.bbrc.2014.07.007 · DOI
- Lin, 2014, Curr Colorectal Cancer Rep, 10, 94, 10.1007/s11888-014-0208-7 · DOI
- Febbo, 2011, J Natl Compr Canc Netw, 9, S1, 10.6004/jnccn.2011.0137 · DOI · Paper page
- Nosho, 2009, Gastroenterology, 137, 1609, 10.1053/j.gastro.2009.08.002 · DOI · Paper page
- Song, 2016, Gut, 65, 296, 10.1136/gutjnl-2014-308852 · DOI
- Chatterjee, 2010, Biometrika, 97, 683, 10.1093/biomet/asq036 · doi:10.1093/biomet/asq036
- Rosner, 2013, Am J Epidemiol, 178, 296, 10.1093/aje/kws457 · DOI
- Wang, 2015, Am J Epidemiol, 182, 263, 10.1093/aje/kwv040 · DOI
- Ogino, 2012, Int J Epidemiol, 41, 1072, 10.1093/ije/dys076 · DOI
- Field, 2013, JAMA, 310, 2147, 10.1001/jama.2013.281501 · DOI
- Yamauchi, 2012, Gut, 61, 847, 10.1136/gutjnl-2011-300865 · DOI · Paper page
- Yamauchi, 2012, Gut, 61, 794, 10.1136/gutjnl-2012-302014 · DOI · Paper page
- Mima, 2015, JAMA Oncol, 1, 653, 10.1001/jamaoncol.2015.1377 · DOI · Paper page
- Ogino, 2014, Oncogene, 33, 2949, 10.1038/onc.2013.244 · DOI
- Ikramuddin, 2013, JAMA, 310, 2401, 10.1001/jama.2013.280927 · DOI
- van Winkel, 2015, Epidemiol Psychiatr Sci, 24, 6, 10.1017/S2045796014000559 · DOI
- Ogino, 2008, J Mol Diagn, 10, 13, 10.2353/jmoldx.2008.070082 · DOI · Paper page
- Lochhead, 2014, Am J Gastroenterol, 109, 1205, 10.1038/ajg.2014.153 · DOI
- Liao, 2012, N Engl J Med, 367, 1596, 10.1056/NEJMoa1207756 · DOI · Paper page
- Domingo, 2013, J Clin Oncol, 31, 4297, 10.1200/JCO.2013.50.0322 · DOI · Paper page
- Fink, 2014, Sci Transl Med, 6, 233re2, 10.1126/scitranslmed.3008481 · DOI
- Chan, 2007, N Engl J Med, 356, 2131, 10.1056/NEJMoa067208 · DOI · Paper page
- Chan, 2009, JAMA, 302, 649, 10.1001/jama.2009.1112 · DOI · Paper page
- Tougeron, 2014, Clin Cancer Res, 20, 1087, 10.1158/1078-0432.CCR-13-2563 · DOI
- Ng, 2011, J Natl Cancer Inst, 103, 1540, 10.1093/jnci/djr307 · DOI
- Lee, 2011, Cancer Prev Res (Phila, 4, 1808, 10.1158/1940-6207.CAPR-11-0113 · DOI
Cited by
Epidemiology of ovarian cancer: a review
Brett M., R., Brett M., R., Jennifer B., P., Thomas A., S., Jennifer B., P., & Thomas A., S. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,524
Is early-onset cancer an emerging global epidemic? Current evidence and future implications
Ugai, T., Sasamoto, N., Lee, H.-Y., Ando, M., Song, M., Tamimi, R. M., Kawachi, I., Campbell, P. T., Giovannucci, E. L., Weiderpass, E., et al. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00672-8 · Cited by 603
Self-citationThe Epidemiology of Esophageal Adenocarcinoma
Coleman, H. G., Xie, S.-H., & Lagergren, J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.07.046 · Cited by 549
Mehta, R. S., Nishihara, R., Cao, Y., Song, M., Mima, K., Qian, Z. R., Nowak, J. A., Kosumi, K., Hamada, T., Masugi, Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.6374 · Cited by 325
“Molecular subtyping in the MPE approach can gather pathogenetically similar cases, and thus can enhance statistical inference (evenwitha relatively smallnumberof cases).(46) Thepresent study represents emerginguniquemicrobialMPE research(47) in which themicrobial feature in tumor tissue can serve as a pathogenic signa…”
Self-citationFusobacterium nucleatum in colorectal carcinoma tissue according to tumor location
Mima, K., Cao, Y., Chan, A. T., Qian, Z. R., Nowak, J. A., Masugi, Y., Shi, Y., Song, M., da Silva, A., Gu, M., et al. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.53 · Cited by 284
Self-citation
Metadata
- Authors
- Ogino, S., Nishihara, R., VanderWeele, T. J., Wang, M., Nishi, A., Lochhead, P., Qian, Z. R., Zhang, X., Wu, K., Nan, H., Yoshida, K., Milner, D. A., Chan, A. T., Field, A. E., Camargo, C. A., Williams, M. A., & Giovannucci, E. L.
- Venue
- Epidemiology
- Published
- 2016-07
- Volume
- 27
- Issue
- 4
- Pages
- 602-611
- ISSN
- 1044-3983 (ISSN-L)
- OpenAlex
- W2291499494
- Cited by
- 177
- References
- 5
- FWCI
- 13.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. https://app.cochat.ai/papers/10.1097/ede.0000000000000471
- The paper
- Ogino, S., Nishihara, R., VanderWeele, T. J., Wang, M., Nishi, A., Lochhead, P., Qian, Z. R., Zhang, X., Wu, K., Nan, H., Yoshida, K., Milner, D. A., Chan, A. T., Field, A. E., Camargo, C. A., Williams, M. A., & Giovannucci, E. L. (2016). Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. Epidemiology. https://doi.org/10.1097/ede.0000000000000471
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.